Microwave assisted synthesis of disubstituted benzyltin arylformylhydrazone complexes: anticancer activity and DNA‐binding properties

[1]  Claudio M. P. de Pereira,et al.  Microwave-assisted extraction and differential scanning calorimetry in the chemical identification of sliming agents apprehended in the south region of Brazil. , 2019, Science & justice : journal of the Forensic Science Society.

[2]  Xiaohe Tian,et al.  A series of two-photon absorption organotin (IV) cyano carboxylate derivatives for targeting nuclear and visualization of anticancer activities. , 2019, Journal of inorganic biochemistry.

[3]  L. Tian,et al.  Structure-activity relationships of 2‑quinolinecarboxaldehyde thiosemicarbazone gallium(III) complexes with potent and selective anticancer activity. , 2019, Journal of inorganic biochemistry.

[4]  E. Aazam,et al.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies , 2019, RSC advances.

[5]  C. Marmion,et al.  Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens? , 2019, Chemical reviews.

[6]  T. Torroba,et al.  Whole microwave syntheses of pyridylpyrazole and of Re and Ru luminescent pyridylpyrazole complexes , 2019, Inorganica Chimica Acta.

[7]  E. Gao,et al.  Two MnII , CuII complexes derived from 3,5-bis(1-imidazoly) pyridine: Synthesis, DNA binding, Molecular docking and cytotoxicity studies , 2018, Applied Organometallic Chemistry.

[8]  M. Yousefi,et al.  Bis-substituted diphenylamine arylidene hydrazones for the synthesis of new binuclear organotin(IV) complexes: Crystal structure, DNA cleavage and molecular docking , 2018, Polyhedron.

[9]  Zeinab Mirzaei-Kalar.  In vitro binding interaction of atorvastatin with calf thymus DNA: multispectroscopic, gel electrophoresis and molecular docking studies , 2018, Journal of pharmaceutical and biomedical analysis.

[10]  D. Cenariu,et al.  Modulation of the mechanism of apoptosis in cancer cell lines by treatment with silica-based nanostructured materials functionalized with different metallodrugs. , 2018, Dalton transactions.

[11]  Y. Qu,et al.  Synthesis, characterization, DNA binding, cytotoxicity and molecular docking properties of Cu (II) and Mn (II) complexes with 1,4-bis (pyrazol-1-yl) terephthalic acid , 2018, Applied Organometallic Chemistry.

[12]  Yanze Yao,et al.  Synthesis, structure and property of diorganotin N -[(3-methoxy-2-oxyphenyl)methylene]tyrosinates , 2018, Applied Organometallic Chemistry.

[13]  M. Lashanizadegan,et al.  New magnetic supported hydrazone Schiff base dioxomolybdenum (VI) complex: An efficient nanocatalyst for epoxidation of cyclooctene and norbornene , 2018, Applied Organometallic Chemistry.

[14]  L. Mondello,et al.  Anti-cancer activity of di- and tri-organotin(IV) compounds with D-(+)-Galacturonic acid on human tumor cells. , 2018, Journal of inorganic biochemistry.

[15]  E. Yashima,et al.  Allosteric regulation of metal-binding sites inside an optically-active helical foldamer and its tubular assemblies. , 2018, Chemical communications.

[16]  Huahong Zou,et al.  A family of 3d metal clusters based on N–N single bonds bridged quasi-linear trinuclear cores: the Mn analogue displaying single-molecule magnet behavior , 2018, RSC advances.

[17]  A. F. Shoair,et al.  Synthesis, structural characterization, molecular docking and DNA binding studies of copper complexes , 2018 .

[18]  Mridula,et al.  Microwave-assisted synthesis of mixed ligands organotin(IV) complexes of 1,10-phenanthroline and l-proline: Physicochemical characterization, DFT calculations, chemotherapeutic potential validation by in vitro DNA binding and nuclease activity. , 2017, Journal of photochemistry and photobiology. B, Biology.

[19]  Zhi-jian Zhang,et al.  Syntheses, crystal structures and biological activity of the dialkytin complexes based on 2-oxo-3-phenylpropionic acid salicyloylhydrazone , 2017 .

[20]  Xin Liu,et al.  Synthesis, crystal structures, DNA/bovine serum albumin binding, DNA cleavage and cytotoxicity of five mononuclear zinc(II) complexes , 2017 .

[21]  Zhang Zhijian,et al.  Syntheses, Crystal Structures and Biological Activity of the 1D Chain Benzyltin Complexes Based on 2-Oxo-Propionic Acid Benzoyl Hydrazone , 2017 .

[22]  H. Höpfl,et al.  Synthesis, characterization, crystal structures and supramolecular features of bicycloazastannoxides derived from Schiff bases with L-tyrosine , 2017 .

[23]  Bruno G. M. Rocha,et al.  New dibutyltin(IV) ladders: Syntheses, structures and, optimization and evaluation of cytotoxic potential employing A375 (melanoma) and HCT116 (colon carcinoma) cell lines in vitro. , 2017, Journal of inorganic biochemistry.

[24]  Saqib Ali,et al.  Organotin(IV) Carboxylates as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy. , 2017, Current pharmaceutical design.

[25]  Meiju Niu,et al.  Anti-proliferative activity and DNA/BSA interactions of five mono- or di-organotin(IV) compounds derived from 2-hydroxy-N′-[(2-hydroxy-3-methoxyphenyl)methylidene]-benzohydrazone , 2016 .

[26]  M. Salam,et al.  Synthesis, structural characterization, and evaluation of biological activity of organotin(IV) complexes with 2-hydroxy-5-methoxybenzaldehyde-N(4)-methylthiosemicarbazone , 2016 .

[27]  R. Subramaniam,et al.  New anticancer zinc(II) complexes comprising thiosemicarbazones of saturated ring: structure, DNA/protein binding, DNA cleavage, topoisomerase‐1 inhibition and anti‐proliferation studies , 2016 .

[28]  P. Inamdar,et al.  Spectroscopic investigations on partial intercalative binding behaviour of terpyridine based copper(II) complexes with DNA. , 2016, Journal of photochemistry and photobiology. B, Biology.

[29]  Saqib Ali,et al.  Synthesis, structural elucidation and DNA binding study of fluorine substituted organotin(IV) dithiocarbamates , 2015 .

[30]  Dacheng Li,et al.  Study of the effect of molecular structure and alkyl groups bound with tin(IV) on their cytotoxicity of organotin(IV) 2-phenyl-4-selenazole carboxylates , 2015 .

[31]  Qingshan Li,et al.  Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  S. Mendo,et al.  New ternary bipyridine–terpyridine copper(II) complexes as self-activating chemical nucleases , 2014 .

[33]  Saqib Ali,et al.  Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA. , 2014, European journal of medicinal chemistry.

[34]  D. Pérez-Quintanilla,et al.  Organotin(IV)-loaded mesoporous silica as a biocompatible strategy in cancer treatment. , 2014, Angewandte Chemie.

[35]  F. Arjmand,et al.  Synthesis, characterization and in vitro DNA binding of chromone Schiff base organotin(IV) complexes , 2013 .

[36]  Saqib Ali,et al.  Catalytic, biological and DNA interaction studies of 3-(4-cyanophenyl)-2-methylacrylate organotin(IV) carboxylates derivatives: Synthesis, spectroscopic characterization and X-ray structures , 2013 .

[37]  Hongyan Liu,et al.  Synthesis, crystal structure and interaction of L-valine Schiff base divanadium(V) complex containing a V2O3 core with DNA and BSA. , 2013, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[38]  H. Yin,et al.  Di- and tri-organotin(IV) complexes with 2-hydroxy-1-naphthaldehyde 5-chloro-2-hydroxybenzoylhydrazone: Synthesis, characterization and in vitro antitumor activities , 2013 .

[39]  H. M. Ali,et al.  Organotin(IV) complexes of 2-hydroxyacetophenone-N(4)-cyclohexylthiosemicarbazone (H2dact): Synthesis, spectral characterization, crystal structure and biological studies , 2012 .

[40]  A. Terzis,et al.  Non-steroidal antiinflammatory drug-copper(II) complexes: structure and biological perspectives. , 2011, Dalton transactions.

[41]  Qingshan Li,et al.  Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands. , 2011, Inorganic chemistry.

[42]  Mahdie Rahban,et al.  Nanotoxicity and Spectroscopy Studies of Silver Nanoparticle: Calf Thymus DNA and K562 as Targets , 2010 .

[43]  E. Tiekink,et al.  Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes , 2011, Investigational New Drugs.

[44]  L. Ji,et al.  Synthesis, DNA-binding and photocleavage studies of ruthenium(II) complexes (Ru(btz) 3 ) 2+ and (Ru(btz)(dppz)2) 2+ , 2009 .

[45]  Shuo Shi,et al.  Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. , 2008, Journal of inorganic biochemistry.

[46]  H. Khavasi,et al.  Synthesis and structural characterization of diorganotin(IV) complexes with 2,6‐pyridinedicarboxylic acid , 2008 .

[47]  C. Pettinari,et al.  Chemical and Biotechnological Developments in Organotin Cancer Chemotherapy , 2006 .

[48]  P. Sadler,et al.  Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. , 2005, Chemical communications.

[49]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[50]  Qingshan Li,et al.  Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity. , 2004, Chemistry.

[51]  N. Turro,et al.  Mixed-ligand complexes of ruthenium(II): factors governing binding to DNA , 1989 .

[52]  Glen B. Deacon,et al.  Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination , 1980 .

[53]  A. J. Bloodworth.  Organotin Chemistry , 1970, Nature.

[54]  J. Trosko,et al.  Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.

[55]  K. Sisido,et al.  Direct Synthesis of Organotin Compounds. I. Di- and Tribenzyltin Chlorides , 1961 .